The general problem of resistance to ␤-lactams, including carbapenems, is significantly exacerbated by aminoglycoside resistance, since they are often employed together in the treatment of the critically ill. In contrast to patterns observed elsewhere (4), amikacin susceptibility is currently preserved in gentamicin-and tobramycin-resistant isolates with transmissible metalloenzymes in Australia (7). However, the emergence of genes such as rmtC with a broad aminoglycoside resistance spectrum (including amikacin) will limit our future options for dealing with all ␤-lactamases.
Nucleotide sequence accession numbers. The nucleotide sequence of the rmtC gene has been submitted to GenBank under accession no. EU144360, and the bla VEB-6 gene has been assigned accession no. EU259884. 
